ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CREO Creo Medical Group Plc

34.50
0.00 (0.00%)
Last Updated: 07:34:45
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Creo Medical Group Plc LSE:CREO London Ordinary Share GB00BZ1BLL44 ORD GBP0.001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 34.50 34.00 35.00 34.50 34.50 34.50 33,661 07:34:45
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Surgical,med Instr,apparatus 27.17M -26.94M -0.0746 -4.62 124.63M
Creo Medical Group Plc is listed in the Surgical,med Instr,apparatus sector of the London Stock Exchange with ticker CREO. The last closing price for Creo Medical was 34.50p. Over the last year, Creo Medical shares have traded in a share price range of 23.25p to 49.50p.

Creo Medical currently has 361,251,418 shares in issue. The market capitalisation of Creo Medical is £124.63 million. Creo Medical has a price to earnings ratio (PE ratio) of -4.62.

Creo Medical Share Discussion Threads

Showing 2326 to 2345 of 2350 messages
Chat Pages: 94  93  92  91  90  89  88  87  86  85  84  83  Older
DateSubjectAuthorDiscuss
18/4/2024
10:08
bloomberg2

Apology accepted.Thank you and I fully agree we can move on and concentrate on CREO.

vasilis
18/4/2024
09:45
Yes I sincerely apologise for any offence my extreme post and misspelling of your name !! Has coursed !! Can we please hold hands together and initiate a complete truce in hostilities! And focus on Creo medical making huge strides in Robotics in the NHS !! Who ever take the keys to number 10
bloomberg2
18/4/2024
09:21
You started the political pivot !!Not me buddy
bloomberg2
18/4/2024
08:12
Typical Left wing Delusional response!!
bloomberg2
17/4/2024
17:23
Sorry Valsillis .... you're thinking on labour in power!! Is Delusional !!
bloomberg2
17/4/2024
16:56
Thanks for posting that link B2.

I think it's a bit rich (no pun intended!) for Sunak to suddenly promote such developments in the NHS when the Tories have underfunded the NHS for years taking inflation into account. 'Dead Man Walking's' pronouncement is not surprising as Labour ratchet up the political noise around the NHS - especially investment in new technology including robotic surgery - as we get nearer to 'hanging time' for the Tories.

It really should be a very nice situation for CREO to be in over the next 5 years as Labour especially are committed to such long overdue developments in the NHS.

vasilis
17/4/2024
14:05
https://x.com/rckhlld/status/1780581747144458619?s=46&t=WZzoFQM8kpCT88d1sI2kew
bloomberg2
17/4/2024
12:35
Robotic surgery get the nod for further investment in the NHS !! Sunak says At Q&A Westminster
bloomberg2
12/4/2024
16:32
Drop without much volume and getting close to year results, MMs looking for cheap shares before update.
nimbo10
12/4/2024
16:14
Crazy price drop !! Unless something sinister in the background!! Technology cutting edge !! Sorry couldn't resist that one
bloomberg2
10/4/2024
23:29
It will be a NICE surprise when the rns drops that's for sure.
master investor
10/4/2024
22:15
Funding is indeed not an issue in this case. Not sure if a sale is nailed on though.
I think holders are going to be in for a nice surprise this year.

pacsltd
10/4/2024
21:21
That is incorrect. You need to do more research. Funding is not an issue, and a sale is nailed on in the next 12-18 months
master investor
10/4/2024
19:21
There is a logical fit with Intuitive which is a key reason I hold a few, but I would prefer them to get into bed as a bolt on the than be taken out. Unfortunately I think they didn't raise enough last time so unless a deal like that is done they will be coming around cap in hand inside the year.
peterrr3
08/4/2024
16:08
Hope so !!
bloomberg2
08/4/2024
15:47
Yeah great volume and increase , this particular share has a great future ahead .
up to the moon and back
08/4/2024
09:02
Nice start
bloomberg2
04/4/2024
10:47
GDR got a NICE recommendation but 12 months from draft guidance. We're still "awaiting development" Since May 2023


NICE recommended in the May 2023 draft guidance. Following a public consultation of this draft guidance, which ends on 26 April 2024, final recommendations are expected to be published by NICE on 10 July 2024.

recommended in draft guidance that the Genedrive® CYP2C19-ID test should be used as the point-of-care ("POC") test of choice before clopidogrel administration in the management of Ischemic Stroke ("IS") and Transient Ischaemic Attack ("TIA") patients.

hatfullofsky
03/4/2024
20:17
But perky today..
edwardt
29/3/2024
11:47
One investor implies they will be taken out by intuitive
dr biotech
Chat Pages: 94  93  92  91  90  89  88  87  86  85  84  83  Older

Your Recent History

Delayed Upgrade Clock